Asset
DIPRAGLURANT
Addex Therapeutics Ltd American Depositary Shares
Revenue
No revenue reported in loaded filings.
Clinical trials (1)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT01336088 | phase2 | completed | 2011-04-01 | 2012-02-01 | Addex Pharma S.A. | ADX48621 for the Treatment of Levodopa Induced Dyskinesia in Patients With Parkinson's Disease |
FDA applications (0)
This company has no applications containing this asset.